U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090304) titled 'China Colorectal Cancer Screening Trial 2 (C-Cost2)' on July 20.
Brief Summary: Colorectal cancer (CRC) is one of the most common malignancies in China. Currently, its incidence rate is increasing at a rate of 4% per year, exceeding the global annual average growth rate. Screening and early diagnosis of colorectal cancer and precancerous lesions are key measures to reduce the disease burden of colorectal cancer in China. In previous clinical studies, colorectal cancer screening in high risk population received extensive attention. However, it cannot be ignored that the majority of sporadic colorectal cancers occur in the average ris...